Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard C Herrmann

Showing results (111-120 of 306) with videos related to

Pageof 31
Sort By:
Journal of the American College of Cardiology|May 21, 2016
Impact of Ejection Fraction and Aortic Valve Gradient on Outcomes of Transcatheter Aortic Valve ReplacementSuzanne J Baron, Suzanne V Arnold, Howard C Herrmann, et al.
Journal of Cardiac Surgery|August 18, 2009
Late surgical mitral valve repair after percutaneous repair with the MitraClip systemJason H Rogers, Khung Keong Yeo, John D Carroll, et al.
Circulation. Cardiovascular Interventions|June 2, 2025
Evaluation of Bioprosthetic Valve Dysfunction in the SMART Randomized Clinical TrialHoward C Herrmann, Daniel J Blackman, Guilherme F Attizzani, et al.
JACC. Cardiovascular Interventions|October 24, 2009
Benefit of facilitated percutaneous coronary intervention in high-risk ST-segment elevation myocardial infarction patients presenting to nonpercutaneous coronary intervention hospitalsHoward C Herrmann, Jiandong Lu, Bruce R Brodie, et al.
Journal of the American College of Cardiology|September 19, 2003
Angiographic variables predict increased risk for adverse ischemic events after coronary stenting with glycoprotein IIb/IIIa inhibition: results from the TARGET trialMitchell J Ross, Howard C Herrmann, David J Moliterno, et al.
The American Journal of Cardiology|October 4, 2014
Analysis of early out-of hospital mortality after transcatheter aortic valve implantation among patients with aortic stenosis successfully discharged from the hospital and alive at 30 days (from the placement of aortic transcatheter valves trial)Nirat Beohar, Alan Zajarias, Vinod H Thourani, et al.
Journal of the American College of Cardiology|December 6, 2005
Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical TrialTed Feldman, Hal S Wasserman, Howard C Herrmann, et al.
Journal of the American College of Cardiology|April 16, 2011
The acute hemodynamic effects of MitraClip therapyRobert J Siegel, Simon Biner, Asim M Rafique, et al.
The American Journal of Cardiology|February 22, 2005
Influence of vessel diameter on the efficacy of distal protection devices during saphenous vein graft interventionAravind Swaminathan, Gregg W Stone, Campbell Rogers, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 13, 2015
Outcomes of transcatheter aortic valve replacement in patients with chronic liver diseaseAnoop M Shah, Jeffrey Ogbara, Howard C Herrmann, et al.
Pageof 31

Showing results (111-120 of 306) with videos related to

Sort By:
Pageof 31
Journal of the American College of Cardiology|May 21, 2016
Impact of Ejection Fraction and Aortic Valve Gradient on Outcomes of Transcatheter Aortic Valve ReplacementSuzanne J Baron, Suzanne V Arnold, Howard C Herrmann, et al.
Journal of Cardiac Surgery|August 18, 2009
Late surgical mitral valve repair after percutaneous repair with the MitraClip systemJason H Rogers, Khung Keong Yeo, John D Carroll, et al.
Circulation. Cardiovascular Interventions|June 2, 2025
Evaluation of Bioprosthetic Valve Dysfunction in the SMART Randomized Clinical TrialHoward C Herrmann, Daniel J Blackman, Guilherme F Attizzani, et al.
JACC. Cardiovascular Interventions|October 24, 2009
Benefit of facilitated percutaneous coronary intervention in high-risk ST-segment elevation myocardial infarction patients presenting to nonpercutaneous coronary intervention hospitalsHoward C Herrmann, Jiandong Lu, Bruce R Brodie, et al.
Journal of the American College of Cardiology|September 19, 2003
Angiographic variables predict increased risk for adverse ischemic events after coronary stenting with glycoprotein IIb/IIIa inhibition: results from the TARGET trialMitchell J Ross, Howard C Herrmann, David J Moliterno, et al.
The American Journal of Cardiology|October 4, 2014
Analysis of early out-of hospital mortality after transcatheter aortic valve implantation among patients with aortic stenosis successfully discharged from the hospital and alive at 30 days (from the placement of aortic transcatheter valves trial)Nirat Beohar, Alan Zajarias, Vinod H Thourani, et al.
Journal of the American College of Cardiology|December 6, 2005
Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical TrialTed Feldman, Hal S Wasserman, Howard C Herrmann, et al.
Journal of the American College of Cardiology|April 16, 2011
The acute hemodynamic effects of MitraClip therapyRobert J Siegel, Simon Biner, Asim M Rafique, et al.
The American Journal of Cardiology|February 22, 2005
Influence of vessel diameter on the efficacy of distal protection devices during saphenous vein graft interventionAravind Swaminathan, Gregg W Stone, Campbell Rogers, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 13, 2015
Outcomes of transcatheter aortic valve replacement in patients with chronic liver diseaseAnoop M Shah, Jeffrey Ogbara, Howard C Herrmann, et al.
Pageof 31